PathologicResponseDocetaxelBilateralProphylacticMastectomyPARPInhibitorsTriplePositiveBreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AdvocacyPalbociclibOligometastasesKappaEpsilonRaloxifeneProgestinER-CheckpointInhibitorTumorGradeGuaranteedRenewableInsuranceFISHWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.EGFR(epidermalgrowth factorreceptor)CachexiaIn-situCarcinomaStagingOvarianSuppressionTamoxifenSERMAlopeciaMRICapecitabineAnastrozoleMegestrolAcetateDoseDenseTherapyBOCAER+Tyrosine-KinaseInhibitorDimplingKi-67RateBrachytherapyFamilyHistoryAdenocarcinomamTORInhibitorsGermlineMutationAxillarySamplingMastodyniaCDK4/6InhibitorsBreastTomosynthesisMethotrexateCo-survivorWomen ages40+ shouldhave a clinicalbreast examat least yearlyHER-2ChemopreventionPhysicalactivity mayreduce therisk of breastcancersCytostaticBreastCancerPhyllodesTumorDown-StagingCyclophosphamideNodePositiveHerceptinLumpectomyEstrogenPaclitaxelCytotoxicRADPagetDiseaseIntraductalPapillomaMastectomyNodeNegativeBI-RADSHormoneReceptorStatusMultimodalityTherapyBevacizumabBiopsyGenomicTestingAntiemeticNeoplasmChemotherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRadiotherapyLCISTripleNegativeBreastCancer5-FluorouracilACChemotherapyApoptosisAdjuvantTherapyAromataseInhibitorsSelf-examinationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenBRCAGeneAntibodyTherapyFlowCytometryInvasiveBreastCancerDefinitiveSurgeryCystEstradiolAyurvedaECOGScorePrecisionMedicineImmunotherapyCalcificationsAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GeneticCounselingHormoneReplacementTherapyGailModelMorpheaGeneMutationPalpationRelapseLymphNodeStatusPI3KinaseInhibitorsLumpLapatinibFibroadenomaAbsoluteRisk1 in 8womenExcisionalBiopsyGeneticPredispositionAngiogenesisCAMLymphoscintigraphyCMFChemotherapyMultifocalTumorsMetastasisNeoadjuvantTherapyDoxorubicinEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearPathologicResponseDocetaxelBilateralProphylacticMastectomyPARPInhibitorsTriplePositiveBreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AdvocacyPalbociclibOligometastasesKappaEpsilonRaloxifeneProgestinER-CheckpointInhibitorTumorGradeGuaranteedRenewableInsuranceFISHWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.EGFR(epidermalgrowth factorreceptor)CachexiaIn-situCarcinomaStagingOvarianSuppressionTamoxifenSERMAlopeciaMRICapecitabineAnastrozoleMegestrolAcetateDoseDenseTherapyBOCAER+Tyrosine-KinaseInhibitorDimplingKi-67RateBrachytherapyFamilyHistoryAdenocarcinomamTORInhibitorsGermlineMutationAxillarySamplingMastodyniaCDK4/6InhibitorsBreastTomosynthesisMethotrexateCo-survivorWomen ages40+ shouldhave a clinicalbreast examat least yearlyHER-2ChemopreventionPhysicalactivity mayreduce therisk of breastcancersCytostaticBreastCancerPhyllodesTumorDown-StagingCyclophosphamideNodePositiveHerceptinLumpectomyEstrogenPaclitaxelCytotoxicRADPagetDiseaseIntraductalPapillomaMastectomyNodeNegativeBI-RADSHormoneReceptorStatusMultimodalityTherapyBevacizumabBiopsyGenomicTestingAntiemeticNeoplasmChemotherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRadiotherapyLCISTripleNegativeBreastCancer5-FluorouracilACChemotherapyApoptosisAdjuvantTherapyAromataseInhibitorsSelf-examinationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenBRCAGeneAntibodyTherapyFlowCytometryInvasiveBreastCancerDefinitiveSurgeryCystEstradiolAyurvedaECOGScorePrecisionMedicineImmunotherapyCalcificationsAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55GeneticCounselingHormoneReplacementTherapyGailModelMorpheaGeneMutationPalpationRelapseLymphNodeStatusPI3KinaseInhibitorsLumpLapatinibFibroadenomaAbsoluteRisk1 in 8womenExcisionalBiopsyGeneticPredispositionAngiogenesisCAMLymphoscintigraphyCMFChemotherapyMultifocalTumorsMetastasisNeoadjuvantTherapyDoxorubicinEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each year

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Pathologic Response
  2. Docetaxel
  3. Bilateral Prophylactic Mastectomy
  4. PARP Inhibitors
  5. Triple Positive Breast Cancer
  6. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  7. Advocacy
  8. Palbociclib
  9. Oligometastases
  10. Kappa Epsilon
  11. Raloxifene
  12. Progestin
  13. ER-
  14. Checkpoint Inhibitor
  15. Tumor Grade
  16. Guaranteed Renewable Insurance
  17. FISH
  18. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  19. EGFR (epidermal growth factor receptor)
  20. Cachexia
  21. In-situ Carcinoma
  22. Staging
  23. Ovarian Suppression
  24. Tamoxifen
  25. SERM
  26. Alopecia
  27. MRI
  28. Capecitabine
  29. Anastrozole
  30. Megestrol Acetate
  31. Dose Dense Therapy
  32. BOCA
  33. ER+
  34. Tyrosine-Kinase Inhibitor
  35. Dimpling
  36. Ki-67 Rate
  37. Brachytherapy
  38. Family History
  39. Adenocarcinoma
  40. mTOR Inhibitors
  41. Germline Mutation
  42. Axillary Sampling
  43. Mastodynia
  44. CDK4/6 Inhibitors
  45. Breast Tomosynthesis
  46. Methotrexate
  47. Co-survivor
  48. Women ages 40+ should have a clinical breast exam at least yearly
  49. HER-2
  50. Chemoprevention
  51. Physical activity may reduce the risk of breast cancers
  52. Cytostatic
  53. Breast Cancer
  54. Phyllodes Tumor
  55. Down-Staging
  56. Cyclophosphamide
  57. Node Positive
  58. Herceptin
  59. Lumpectomy
  60. Estrogen
  61. Paclitaxel
  62. Cytotoxic
  63. RAD
  64. Paget Disease
  65. Intraductal Papilloma
  66. Mastectomy
  67. Node Negative
  68. BI-RADS
  69. Hormone Receptor Status
  70. Multimodality Therapy
  71. Bevacizumab
  72. Biopsy
  73. Genomic Testing
  74. Antiemetic
  75. Neoplasm
  76. Chemotherapy
  77. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  78. Radiotherapy
  79. LCIS
  80. Triple Negative Breast Cancer
  81. 5-Fluorouracil
  82. AC Chemotherapy
  83. Apoptosis
  84. Adjuvant Therapy
  85. Aromatase Inhibitors
  86. Self-examination
  87. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  88. BRCA Gene
  89. Antibody Therapy
  90. Flow Cytometry
  91. Invasive Breast Cancer
  92. Definitive Surgery
  93. Cyst
  94. Estradiol
  95. Ayurveda
  96. ECOG Score
  97. Precision Medicine
  98. Immunotherapy
  99. Calcifications
  100. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  101. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  102. Genetic Counseling
  103. Hormone Replacement Therapy
  104. Gail Model
  105. Morphea
  106. Gene Mutation
  107. Palpation
  108. Relapse
  109. Lymph Node Status
  110. PI3 Kinase Inhibitors
  111. Lump
  112. Lapatinib
  113. Fibroadenoma
  114. Absolute Risk
  115. 1 in 8 women
  116. Excisional Biopsy
  117. Genetic Predisposition
  118. Angiogenesis
  119. CAM
  120. Lymphoscintigraphy
  121. CMF Chemotherapy
  122. Multifocal Tumors
  123. Metastasis
  124. Neoadjuvant Therapy
  125. Doxorubicin
  126. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year